FARMACOSMO SPA (COSMO.MI) Stock Fundamental Analysis

BIT:COSMO • IT0005487670

0.518 EUR
-0.04 (-6.83%)
Last: Feb 26, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

2

COSMO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 59 industry peers in the Specialty Retail industry. COSMO may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, COSMO is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year COSMO has reported negative net income.
  • In the past year COSMO has reported a negative cash flow from operations.
  • In multiple years COSMO reported negative net income over the last 5 years.
  • In the past 5 years COSMO reported 4 times negative operating cash flow.
COSMO.MI Yearly Net Income VS EBIT VS OCF VS FCFCOSMO.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -16.93%, COSMO is doing worse than 87.93% of the companies in the same industry.
  • COSMO has a worse Return On Equity (-65.88%) than 84.48% of its industry peers.
Industry RankSector Rank
ROA -16.93%
ROE -65.88%
ROIC N/A
ROA(3y)-7.87%
ROA(5y)-3.1%
ROE(3y)-21.54%
ROE(5y)9.09%
ROIC(3y)N/A
ROIC(5y)N/A
COSMO.MI Yearly ROA, ROE, ROICCOSMO.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

  • COSMO's Gross Margin of 5.88% is on the low side compared to the rest of the industry. COSMO is outperformed by 87.93% of its industry peers.
  • COSMO's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for COSMO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3%
GM growth 5Y2.63%
COSMO.MI Yearly Profit, Operating, Gross MarginsCOSMO.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4 6

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • COSMO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, COSMO has about the same amount of shares outstanding.
  • The number of shares outstanding for COSMO has been increased compared to 5 years ago.
  • Compared to 1 year ago, COSMO has a worse debt to assets ratio.
COSMO.MI Yearly Shares OutstandingCOSMO.MI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M
COSMO.MI Yearly Total Debt VS Total AssetsCOSMO.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • COSMO has an Altman-Z score of 1.83. This is not the best score and indicates that COSMO is in the grey zone with still only limited risk for bankruptcy at the moment.
  • COSMO has a Altman-Z score (1.83) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.84 indicates that COSMO is somewhat dependend on debt financing.
  • The Debt to Equity ratio of COSMO (0.84) is worse than 62.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Altman-Z 1.83
ROIC/WACCN/A
WACC7%
COSMO.MI Yearly LT Debt VS Equity VS FCFCOSMO.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

  • A Current Ratio of 1.22 indicates that COSMO should not have too much problems paying its short term obligations.
  • The Current ratio of COSMO (1.22) is comparable to the rest of the industry.
  • COSMO has a Quick Ratio of 1.22. This is a bad value and indicates that COSMO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • COSMO has a Quick ratio (0.50) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.5
COSMO.MI Yearly Current Assets VS Current LiabilitesCOSMO.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The earnings per share for COSMO have decreased strongly by -98.41% in the last year.
  • COSMO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.95%.
  • COSMO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.99% yearly.
EPS 1Y (TTM)-98.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-172.3%
Revenue 1Y (TTM)-12.95%
Revenue growth 3Y2.78%
Revenue growth 5Y20.99%
Sales Q2Q%-14.57%

3.2 Future

  • Based on estimates for the next years, COSMO will show a very strong growth in Earnings Per Share. The EPS will grow by 41.42% on average per year.
  • Based on estimates for the next years, COSMO will show a quite strong growth in Revenue. The Revenue will grow by 13.48% on average per year.
EPS Next Y33.33%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.4%
Revenue Next 2Y13.48%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
COSMO.MI Yearly Revenue VS EstimatesCOSMO.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
COSMO.MI Yearly EPS VS EstimatesCOSMO.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 0 -0.02 -0.04 -0.06

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for COSMO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
COSMO.MI Price Earnings VS Forward Price EarningsCOSMO.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
COSMO.MI Per share dataCOSMO.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as COSMO's earnings are expected to grow with 41.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for COSMO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

FARMACOSMO SPA

BIT:COSMO (2/26/2026, 7:00:00 PM)

0.518

-0.04 (-6.83%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners5.8%
Inst Owner ChangeN/A
Ins Owners15.29%
Ins Owner ChangeN/A
Market Cap18.01M
Revenue(TTM)58.27M
Net Income(TTM)-4.83M
AnalystsN/A
Price Target1.35 (160.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.31
P/FCF N/A
P/OCF N/A
P/B 2.45
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS1.68
BVpS0.21
TBVpS-0.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -16.93%
ROE -65.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.88%
FCFM N/A
ROA(3y)-7.87%
ROA(5y)-3.1%
ROE(3y)-21.54%
ROE(5y)9.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3%
GM growth 5Y2.63%
F-Score2
Asset Turnover2.04
Health
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 58.2%
Cap/Sales 2.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 0.5
Altman-Z 1.83
F-Score2
WACC7%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-98.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-172.3%
EPS Next Y33.33%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.95%
Revenue growth 3Y2.78%
Revenue growth 5Y20.99%
Sales Q2Q%-14.57%
Revenue Next Year10.4%
Revenue Next 2Y13.48%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year202.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.82%
OCF growth 3YN/A
OCF growth 5YN/A

FARMACOSMO SPA / COSMO.MI FAQ

What is the ChartMill fundamental rating of FARMACOSMO SPA (COSMO.MI) stock?

ChartMill assigns a fundamental rating of 2 / 10 to COSMO.MI.


Can you provide the valuation status for FARMACOSMO SPA?

ChartMill assigns a valuation rating of 1 / 10 to FARMACOSMO SPA (COSMO.MI). This can be considered as Overvalued.


What is the profitability of COSMO stock?

FARMACOSMO SPA (COSMO.MI) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for COSMO stock?

The Earnings per Share (EPS) of FARMACOSMO SPA (COSMO.MI) is expected to grow by 33.33% in the next year.